<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Hyperuricemia Management Strategies &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/hyperuricemia-management-strategies/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 12:50:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Hyperuricemia Management Strategies &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Hyperuricemia: Latest Insights and Future Directions in Research</title>
		<link>https://bioengineer.org/hyperuricemia-latest-insights-and-future-directions-in-research/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 19 Mar 2025 18:36:10 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Cardiovascular risks in hyperuricemia]]></category>
		<category><![CDATA[Genetic Factors in Uric Acid Metabolism]]></category>
		<category><![CDATA[Genetic predispositions for hyperuricemia]]></category>
		<category><![CDATA[Gout and Metabolic Syndrome]]></category>
		<category><![CDATA[Gut microbiota and uric acid metabolism]]></category>
		<category><![CDATA[Hyperuricemia and Gut Microbiota]]></category>
		<category><![CDATA[Hyperuricemia Management Strategies]]></category>
		<category><![CDATA[Hyperuricemia treatment innovations]]></category>
		<category><![CDATA[Lifestyle interventions for uric acid control]]></category>
		<category><![CDATA[Uric Acid and Cardiovascular Diseases]]></category>
		<guid isPermaLink="false">https://bioengineer.org/hyperuricemia-latest-insights-and-future-directions-in-research/</guid>

					<description><![CDATA[Hyperuricemia: A Comprehensive Overview of Current Understanding and Management Approaches Hyperuricemia (HU) has emerged as a significant global health issue, manifesting as elevated uric acid (UA) levels in the bloodstream. This condition is primarily identified when UA concentrations exceed 420 µmol/L (7 mg/dL) in males and 350 µmol/L (6 mg/dL) in females. Underlying this seemingly [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">238751</post-id>	</item>
	</channel>
</rss>
